We are live on ! Find out more
EM

Excalibur Management Portfolio holdings

AUM $278M
1-Year Est. Return 20.09%
This Fund
S&P 500
This Quarter Est. Return
-0.3%
1 Year Est. Return
+20.09%
3 Year Est. Return
+68.93%
5 Year Est. Return
+93.63%
10 Year Est. Return
+240.99%
AUM
$231M
AUM Growth
-$17M
Cap. Flow
-$14.2M
Cap. Flow %
-6.17%
Top 10 Hldgs %
36.48%
Holding
164
New
6
Increased
38
Reduced
92
Closed
9

Top Buys

Rank Stock Value
1
SHEL icon
Shell
SHEL
+$1.2M
2
META icon
Meta Platforms (Facebook)
META
+$928K
3
HD icon
Home Depot
HD
+$744K
4
MMM icon
3M
MMM
+$570K
5
NVDA icon
NVIDIA
NVDA
+$528K

Sector Composition

Rank Sector Weight
1 Industrials 17.6%
2 Healthcare 17.51%
3 Financials 14.58%
4 Technology 14%
5 Consumer Staples 8.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSL icon
1
Carlisle Companies
CSL
$13.5B
$19.8M 8.58%
80,522
-184
-0.2% -$43.1K
AAPL icon
2
Apple
AAPL
$4.97T
$10.9M 4.72%
62,355
-645
-1% -$108K
MSFT icon
3
Microsoft
MSFT
$2.9T
$9.08M 3.93%
29,443
-322
-1% -$96.9K
PFE icon
4
Pfizer
PFE
$143B
$8.02M 3.48%
154,938
-877
-0.6% -$45.5K
BRK.B icon
5
Berkshire Hathaway Class B
BRK.B
$1.1T
$8M 3.47%
22,669
-2,876
-11% -$930K
JNJ icon
6
Johnson & Johnson
JNJ
$640B
$7.13M 3.09%
40,212
+113
+0.3% +$19.2K
VZ icon
7
Verizon
VZ
$197B
$5.88M 2.55%
115,355
+2,536
+2% +$134K
MRK icon
8
Merck
MRK
$322B
$5.41M 2.34%
65,900
+1,803
+3% +$142K
JPM icon
9
JPMorgan Chase
JPM
$916B
$5.08M 2.2%
37,268
+681
+2% +$101K
CVS icon
10
CVS Health
CVS
$135B
$4.89M 2.12%
48,351
-2,169
-4% -$228K
T icon
11
AT&T
T
$164B
$4.54M 1.97%
254,166
-19,014
-7% -$352K
PG icon
12
Procter & Gamble
PG
$340B
$4.28M 1.86%
28,017
-642
-2% -$100K
VCSH icon
13
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$3.97M 1.72%
50,816
-24,617
-33% -$1.96M
CVX icon
14
Chevron
CVX
$382B
$3.24M 1.4%
19,883
-2,489
-11% -$357K
V icon
15
Visa
V
$677B
$3.14M 1.36%
14,142
-114
-0.8% -$24.7K
INTC icon
16
Intel
INTC
$413B
$3.01M 1.3%
60,756
+2,766
+5% +$137K
WPC icon
17
W.P. Carey
WPC
$17B
$2.9M 1.26%
36,599
-88
-0.2% -$6.75K
PEP icon
18
PepsiCo
PEP
$196B
$2.86M 1.24%
17,103
-221
-1% -$37.1K
SPSB icon
19
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
$2.69M 1.16%
89,158
-49,442
-36% -$1.51M
XOM icon
20
ExxonMobil
XOM
$650B
$2.67M 1.16%
32,346
-10,821
-25% -$841K
ABBV icon
21
AbbVie
ABBV
$465B
$2.62M 1.13%
16,157
+796
+5% +$116K
UPS icon
22
United Parcel Service
UPS
$88.9B
$2.45M 1.06%
11,411
-1,144
-9% -$243K
INDB icon
23
Independent Bank
INDB
$4.04B
$2.33M 1.01%
28,465
META icon
24
Meta Platforms (Facebook)
META
$1.49T
$2.29M 0.99%
10,304
+3,712
+56% +$928K
CSCO icon
25
Cisco
CSCO
$443B
$2.24M 0.97%
40,120
-132
-0.3% -$7.47K

Similar funds

Excalibur Management's Q1 2022 Portfolio in Review

As of Q1 2022, Excalibur Management held 164 positions worth $231M, down 6.9% from $248M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Excalibur Management withdrew a net $14.2M in Q1 2022, closing 9 positions and reducing 92 holdings. Its most notable exit was iShares 1-3 Year Treasury Bond ETF, an estimated $7.1M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Excalibur Management opened a new position in Shell worth $1.24M.

  • Excalibur Management's largest Q1 2022 buy was Shell: 22,517 shares worth $1.24M.
  • Excalibur Management added most to Meta Platforms (Facebook) in Q1 2022, an estimated $928K increase.
  • Excalibur Management's biggest Q1 2022 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.96M.
  • Excalibur Management fully exited iShares 1-3 Year Treasury Bond ETF in Q1 2022, selling an estimated $7.1M.
  • Excalibur Management's ten largest holdings make up 36% of its $231M portfolio in Q1 2022.
  • Excalibur Management opened 6 new positions and closed 9 in Q1 2022.
  • Excalibur Management's portfolio value fell 6.9% quarter-over-quarter to $231M.

Based on Excalibur Management's 13F filing for Q1 2022, filed 3 May 2022.